stockrow
Friday 6 November 2026
Export SSII’s income statement to Excel — free account
SS Innovations International, Inc.
SSII Healthcare Medical Devices
SS Innovations International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $42.5 million, up 105.7% from fiscal 2024.
- Revenue
- +39.4%
- EPS
- −669.2%
- Free cash flow
- −16.6%
- Total debt
- +109.7%
Quarter to June 2026, against a year earlier
2.20
0.30
+15.79%
Follow SSII
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | — | — | — | — | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Altman Z-Score |
17.50 | 25.70 | 50.88 | — | — | — | — | — | — | — |
P/S ratio |
25.40 | 65.28 | 178.76 | 0.00 | — | — | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(0.08) | (4.94) | (2.41) | (13.38) | — | — | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Beneish M-Score |
(0.72) | (2.09) | 0.72 | — | — | — | — | — | — | — |
P/Operating CF |
(710.22) | (413.28) | (324.90) | (3,259.73) | — | — | — | — | — | — |
P/B ratio |
28.24 | 100.17 | 53.27 | 1,628.93 | — | — | — | — | — | — |
Price to Tangible BV |
28.27 | 100.49 | 53.38 | 1,862.09 | — | — | — | — | — | — |
EV/Sales |
25.46 | 65.36 | 178.67 | 0.00 | — | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
EV/Operating CF |
(58.33) | (142.03) | (68.34) | (100.30) | — | — | — | — | — | — |
EV/FCF |
(48.71) | (132.78) | (67.51) | (105.20) | — | — | — | — | — | — |
Quick Ratio |
0.82 | 0.51 | 1.06 | 0.19 | 1.41 | 0.14 | 0.02 | 0.10 | 1.11 | 0.38 |
Current Ratio |
1.86 | 1.29 | 2.53 | 0.60 | 1.42 | 0.14 | 0.03 | 0.11 | 1.13 | 0.38 |
Net Debt/EBITDA |
(0.32) | (0.09) | 0.03 | (0.30) | 0.29 | 0.15 | 0.01 | 0.04 | 0.45 | 0.54 |
Debt/Assets |
15.42% | 18.86% | 20.72% | 37.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.30 | 0.59 | 0.33 | (1.32) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.73 | 0.56 | 0.29 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
1.53 | 0.50 | 0.74 | 0.99 | 0.24 | 0.08 | 0.13 | 0.46 | 0.43 | 0.44 |
Capex/Depreciation |
(3.40) | (1.52) | (2.97) | 2.05 | 0.00 | (0.11) | (1.33) | (0.47) | (5.25) | 0.00 |
Interest Coverage |
(7.39) | (19.50) | (22.66) | (35.06) | — | (1,002.64) | (170.87) | — | (37.44) | (20.56) |
| (46.94%) | (115.45%) | (241.96%) | 483.05% | 407.94% | 116.41% | 526.47% | 1,575.55% | 817.09% | 0.00% | |
| (20.80%) | (51.83%) | (103.89%) | (123.04%) | (397.67%) | (499.42%) | (2,436.85%) | (293.04%) | (258.71%) | 0.00% | |
ROIC |
(12.64%) | (78.30%) | (66.01%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(38.31%) | (166.94%) | (152.83%) | 138.95% | (1,050.46%) | 114.10% | 314.57% | 329.21% | (1,804.70%) | 121.68% |
Average Days of Receivables |
106.52 | 78.94 | 118.11 | 148.25 | — | — | — | — | — | — |
Research and Development Expense of Revenue |
8.68% | 12.07% | 18.02% | 5.71% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
54.08% | 118.65% | 336.80% | 417.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 |
Share Based Compensation of Revenue |
19.13% | 69.46% | 251.69% | 59.35% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.01 | 0.00 | 0.01 | 0.00 | — | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.43 | — | — | — | — | — | — |
Earnings Yield |
(1.08%) | (1.42%) | (1.99%) | (2.00%) | — | — | — | — | — | — |
Free Cash Flow Yield |
(2.06%) | (0.75%) | (1.48%) | (0.96%) | — | — | — | — | — | — |
Revenue per Share |
0.22 | 0.12 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.10) | (0.06) | (0.11) | (0.14) | (0.01) | 0.00 | (0.02) | (0.02) | (0.02) | (0.01) |
Capex per Share |
(0.02) | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.12) | (0.06) | (0.11) | (0.13) | (0.01) | 0.00 | (0.02) | (0.02) | (0.02) | (0.01) |
Cash per Share |
0.05 | 0.04 | 0.05 | 0.04 | 0.01 | 0.01 | 0.00 | 0.00 | 0.02 | 0.01 |
Shareholders Equity per Share |
0.20 | 0.08 | 0.14 | (0.06) | 0.01 | (0.04) | (0.05) | (0.01) | 0.01 | (0.02) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.20 | 0.08 | 0.14 | (0.06) | 0.01 | (0.04) | (0.05) | (0.01) | 0.01 | (0.02) |
Free Cash Flow |
(22.20) | (10.16) | (15.81) | (5.29) | (0.36) | (0.09) | (0.47) | (0.45) | (0.45) | (0.26) |
Working Capital |
22.56 | 6.09 | 12.96 | (4.42) | 0.12 | (1.02) | (1.16) | (0.33) | 0.05 | (0.40) |
Capital Expenditures |
(3.66) | (0.66) | (0.45) | 0.26 | — | 0.00 | (0.05) | (0.01) | 0.00 | (0.04) |
Net Current Asset Value |
12.79 | (1.51) | 9.63 | (4.42) | 0.12 | (1.02) | (1.16) | (0.33) | 0.05 | (0.40) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Capex to Sales |
0.09 | 0.03 | 0.08 | (0.18) | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.12 | 0.08 | 0.22 | 0.33 | 0.92 | 0.98 | 0.45 | 0.55 | 0.24 | — |
Cash ROIC |
(37.76%) | (36.62%) | (47.49%) | (225.07%) | (66.35%) | 13.34% | 45.82% | 241.59% | (81.47%) | 238.91% |
Accounts Receivable Turnover |
5.04 | 6.49 | 4.71 | 0.00 | — | — | — | — | — | — |
Accounts Payable Turnover |
6.17 | 7.59 | 6.77 | 2.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
1.68 | 1.42 | 1.31 | 0.00 | — | — | — | — | — | — |
Average Days of Payables |
81.58 | 69.20 | 63.90 | 233.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
271.50 | 305.44 | 497.40 | 322.46 | — | — | — | — | — | — |
Average Receivables |
8.43 | 3.18 | 1.25 | — | — | — | — | — | — | — |
Average Payables |
3.72 | 1.61 | 0.76 | 0.37 | 0.13 | 0.14 | 0.08 | 0.01 | 0.03 | — |
Average Inventory |
13.64 | 8.61 | 3.94 | — | — | — | — | — | — | — |
Average Assets |
58.31 | 36.95 | 20.10 | 4.55 | 0.37 | 0.23 | 0.14 | 0.33 | 0.40 | — |
Average Common Equity |
25.84 | 16.59 | 8.63 | (1.16) | (0.36) | (0.97) | (0.64) | (0.06) | (0.13) | — |
Columns are period end dates · fundamentals updated 25 Oct 2026